162 results
Page 2 of 9
6-K
EX-99.1
kxak vz9knacnr6b5
26 Jun 23
Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
8:03am
6-K
EX-99.2
xa0uz4sidbs0
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
6n4ur6u1095uzve8vh6
31 May 23
Report of Foreign Private Issuer
8:09am
6-K
EX-99.1
n1w70b6
8 May 23
Enlivex Announces Issuance of European Patent Covering the Use of Allocetra™ to
8:02am
6-K
EX-99.1
brkjfdumivw3
19 Apr 23
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
8:03am
6-K
EX-99.1
srrq9y 0xhqf
17 Apr 23
Enlivex Appoints Andrew Singer to its Board of Directors
8:03am
6-K
EX-99.1
k2cbxjjdk07jgwwr07ra
4 Apr 23
Enlivex Announces Tislelizumab Clinical Collaboration, Full Year 2022 Financial Results, and Provides Business Updates
8:05am
6-K
1e3o i03gdn1zfc6
3 Apr 23
Enlivex Announces Clinical Collaboration to Evaluate Combinations of Allocetra and PD-1 Inhibitor Tislelizumab for Patients with Solid Tumors
8:05am
6-K
EX-99.1
0qvht zi7k2rxt17sj5
3 Apr 23
Enlivex Announces Clinical Collaboration to Evaluate Combinations of Allocetra and PD-1 Inhibitor Tislelizumab for Patients with Solid Tumors
8:05am
6-K
EX-10.1
sunodq5t0i
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
et85vepn87bq 1sk2hmz
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
fjltkyz
5 Dec 22
Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
8:05am
6-K
EX-99.2
qnwgb2ofh
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
lauing58g9q945i
28 Nov 22
Enlivex Receives Allocetra IND Clearance From The U.S. Food And Drug Administration For Treatment Of Patients with Advanced Solid Malignancies
8:01am
6-K
EX-99.1
x3k28xjb8z0 5zw2
15 Nov 22
Report of Foreign Private Issuer
8:01am
6-K
s4sl k1z3jj
15 Nov 22
Report of Foreign Private Issuer
8:01am
6-K
EX-99.1
jj3o jp6a
12 Sep 22
Report of Foreign Private Issuer
8:02am
6-K
EX-99.1
ukz3oc16
6 Sep 22
Report of Foreign Private Issuer
8:06am
6-K
EX-99.1
z5yb 8nvjflzj
29 Aug 22
Enlivex Receives Notice of Allowance for Japanese Patent Application Covering Allocetra Derived from Pooled Donor Cells
8:01am